investments ↘

Our portfolio
companies.

Industry
Stage
Geographical Area
Focus
Industry: Digital Wellbeing
Stage: Founding Shares
Geographical Area: Basel Switzerland
Focus: Longevity SaaS

Aera Health is an AI-powered platform started in part by Infinitas Capital that enhances patient-centered care by empowering healthcare providers with expert insights, personalized health plans, and streamlined workflows. It facilitates better doctor-patient collaboration, automates routine tasks, and improves treatment outcomes through advanced data analytics.

Industry: Biotechnology
Stage: Series B
Geographical Area: Los Altos, US
Focus: BioTech Precision Psychiatry

Alto Neuroscience utilizes an AI-enabled biomarker platform to develop personalized and highly effective medicines. The platform allows the company to identify likely responders for drug therapies and can highlight the signals behind effective compounds. It is based on 10+ years of research at Professor Etkin’s lab at Stanford.

Industry: Biotechnology
Stage: Pre-Seed
Geographical Area: Berlin, Germany
Focus: Longevity Proteasome Activation

Booster Therapeutics is pioneering a new class of medicines that activate the cell’s natural quality control machinery to treat a range of complex indications. Booster’s small molecule therapeutics, discovered through the DGRADX™ platform, are designed to directly boost the activity of 20S proteasomes to restore the body’s ability to clear disease-causing proteins. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function such as Parkinson’s disease and Alzheimer’s disease.

Industry: Biotechnology
Stage: Series B/C
Geographical Area: US New York
Focus: Longevity Various Targets

Cambrian is a Distributed Development Company with the ultimate goal of preventing illness across all the recognised signs of ageing by combining biomedical breakthroughs with a data-driven strategy to build a pipeline of therapies. Cambrian is building the medicines that will redefine healthcare in the 21st century – therapeautics to lenghten health span, the period of life spent in good health.

Industry: Biotechnology
Stage: Convertible
Geographical Area: Netherlands
Focus: Longevity Cellular Senescence

Cleara is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases through selective elimination of subtypes of cellular senescence.

Industry: Biotechnology
Stage: SAFE
Geographical Area: US New York
Focus: BioTech Female Health

Gameto is a biotechnology company applying cellular reprogramming to create human reprogrammed cells of the ovary, including granulosa cells and oocytes precursors. The company aims to: improve assisted fertility to eliminate infertility over time, create a computational platform for ovarian aging, and make the medical burden of menopause optional.

Industry: Biotechnology
Stage: Seed
Geographical Area: Berlin Germany
Focus: Longevity FOXO

Refoxy is developing therapeutic medicines intended to treat age-related diseases and improve healthy longevity. The company studies FOXO proteins, which control multiple genes involved in activities such as stress resistance and metabolism and develops innovative modulators of a central stress reponse pathway to alter the genetics of ageing and increase healthy life span.

Industry: Biotechnology
Stage: Convertible
Geographical Area: Schlieren Switzerland Zürich
Focus: Longevity Various Targets

Centenara Labs is a fully integrated BioTech company that invests in and supports innovators in the field of aging to transform their scientific discoveries into medicines with the aim to enable people to live healthier, longer lives by lowering the burden of age-related disorders. Centenara Labs is continuously seeking transformational ideas to launch new entities in the longevity area or to cooperate on initiatives and technologies already within Centenara Labs.

Industry: Biotechnology
Stage: Series A
Geographical Area: Boston US
Focus: Longevity Restoring Autophagy

Samsara Therapeutics Inc. is biopharmaceutical company aiming to discover first-in-class therapeutics that treat rare genetic and neurodegenerative disease, and extend healthy lifespan. Samsara’s platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy. Samsara Therapeutics is a global biotech company with operations in Oxford and Boston and significant academic collaborations in Paris and Graz.

Industry: Biotechnology
Stage: Seed
Geographical Area: US
Focus: Longevity

Stealth company attempting to boost life expectancy via molecular interventions. In particular, the company is testing a compound for the purpose of clinical approval to extend human lifespan.

Industry: Edtech and Mental Wellbeing
Stage: Seed
Geographical Area: US
Focus: Well-being

Storypod is a US-based toy company specialising in screenless audio platforms for children and operating in the EdTech market.
The company makes an interactive screen-free audio system for kids that makes stage-based learning fun. Such an experience is important for the mental health of a growing child as well as their social and emotional development. Storypod is consistently praised by parents, especially ones with children with disabilities.